Remove 2019 Remove Communication Remove Documentation
article thumbnail

Vital Pharma -Walk-In Drive for Freshers & Experienced in Accounts & Maintenance On 17th & 18th Feb’ 2023@ Hyderabad

Pharma Pathway

Working: Corporate Office’ Secunderabad Department: Maintenance (Formulation) -Assistant Manager Qualification: Diploma / B.Tech Experience: 05-08 years (Pass Out: 2019 to 2022) Skills: OSD/ OLD-Manufacturing (Formulation), maintenance management, HVAC, Water System, EHS Knowledge, Air Compressor, Documentation, Vacuum pumps.

article thumbnail

Speaking of Medicine – Mid-Year OPDP Enforcement Review

Eye on FDA

There are two means of gaining insight into the agency’s thinking about regulatory issues related to promotional communications by pharmaceutical companies; one is through the issuance of guidance documents, the other is through enforcement. But when it comes to enforcement things have changed greatly over the years.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

New regulatory relief to benefit Europe’s pharma SMEs

European Pharmaceutical Review

As small and medium-sized enterprises (SMEs) often face unfair competition when doing business in Europe, through the (SME) Relief Communication, the European Commission (EC) has proposed new measures to provide short-term relief, boost long-term competitiveness, and improve equality in the business environment across the Single Market in Europe.

article thumbnail

White paper reveals pathway for digital therapeutics use in Italy

pharmaphorum

The experts were also involved in the “Digital Therapeutics for Italy – #DTxITA”, established in 2019 to encourage the implementation of DTx in Italian institutions and healthcare systems. Healthware Group, an international integrated consulting group also based in Italy, contributed to the white paper.

article thumbnail

Teva faces EU antitrust probe over MS drug Copaxone

pharmaphorum

The Commission will also examine whether Teva may have launched a communication campaign to create a “false perception” about the health risks of prescribing generic competitors, aimed at healthcare professionals and hospitals.

article thumbnail

NHC Comments on Key Information and Facilitating Understanding in Informed Consent

Putting Patients First Blog

Key Points of Support Conciseness and Focus of Key Information The NHC supports the FDA’s emphasis on beginning the informed consent document with concise, focused presentations of key information. Clarity in communication is not just about convenience; it is a fundamental aspect of ethical medical practice and research.

article thumbnail

State of Well-Being 2023-2024

The Happy PharmD

Based on the data, the average distress level among pharmacists has decreased compared to previous reports spanning from 2019 to 2022. in 2019 to 2.59. The stress experienced by community pharmacists compared to those in other settings is well-documented and has been a longstanding issue. It has declined from 3.25